Key facts
- Seluna’s last known valuation is $3.6M (Aug 2025).
- It has raised $1.4M; the latest was Early Stage VC ($1.0M) in Aug 2025.
- Notable investors include Scottish Enterprise, Orchard Ventures, Techscaler (UK), Gabriel Investment Syndicate, Innovate UK Business Connect — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Seluna
- ·The full record, as it builds
Funding rounds
No funding rounds for Seluna are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Seluna
Developer of medical software designed to help doctors rapidly diagnose pediatric sleep disorders and prioritize treatment for children in urgent need. The company's platform offers advanced diagnostic algorithms and streamlined data analysis, enabling healthcare providers to deliver timely and targeted care for young patients.
- Sector
- Healthcare
- HQ
- Dunblane, United Kingdom
- Founded
- 2022
- Employees
- 8
- Website
- seluna.co.uk/
- Ownership
- Privately Held (backing)
Seluna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Seluna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Seluna in its N-PORT filings yet. We sweep new filings monthly.